Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Marc Yates
  • November 24, 2020
  • Videos

Meet the Emerging Markets team

In this short video our dedicated team of emerging market experts highlight how we can help you maximise your competitive advantage in the markets offering the best opportunities for growth.

read more »

  • Posted by Paul Reed
  • November 23, 2020
  • Articles

Facial analysis in emerging markets

Facial analysis in emerging markets

One of the latest innovations in market research is facial and emotional analysis using artificial intelligence. This technology employs recognition software to detect emotional insights from facial expressions, which can enhance research by delving further into respondents’ reactions to healthcare communications or other stimuli. Complementary tools can be used to elicit additional meaning from tone of voice, through to laughter and anger.

read more »

  • Posted by Marc Yates & An-hwa Lee
  • November 20, 2020
  • Webinars

China: How pharma can maximise success in this rapidly changing emerging market

China: How pharma can maximise success in this rapidly changing emerging market

Watch this webcast in which our emerging market experts provide an overview of the healthcare environment in China, key opportunities for pharma and discuss case studies which showcase how to implement an effective marketing strategy in this rapidly changing market. 

read more »

  • Posted by Rachel Howard
  • October 22, 2020
  • Articles

WeChat study: Living with HIV in China

WeChat study: Living with HIV in China

As a company, Research Partnership has been exploring new digital market research methodologies as a way to capture deeper insights. In a previous article, I investigated how WhatsApp can be used as a quick, exploratory, multimedia messaging platform for market research in LATAM due to its ubiquity in the region. Subsequently, we wanted to see whether WeChat could be used in a similar way in China, given its dominance across the country.

read more »

  • Posted by Pei Li Teh
  • September 22, 2020
  • Articles

Developing Biosimilars in Asia

Developing Biosimilars in Asia

Biologics currently make up half of the pharmacological market for oncology, but the steep cost of these drugs is a barrier to access globally.

In 3 years’ time, patents on nearly 20 oncology biologics will expire, which is likely to result in the launch of biosimilars offering reduced prices. In the past, the biosimilars market was focused in Europe and the US. However, biosimilars have recently begun to emerge in countries with existing biopharmaceutical infrastructure and companies.

read more »